The WACC of RELIEF THERAPEUTICS Holding SA (RLF.SW) is 5.2%.
| Range | Selected | |
| Cost of equity | 4.40% - 6.20% | 5.30% |
| Tax rate | 9.50% - 11.80% | 10.65% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.4% - 6.1% | 5.2% |
| Category | Low | High |
| Long-term bond rate | 1.0% | 1.5% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.47 | 0.53 |
| Additional risk adjustments | 1.0% | 1.5% |
| Cost of equity | 4.40% | 6.20% |
| Tax rate | 9.50% | 11.80% |
| Debt/Equity ratio | 0.07 | 0.07 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.4% | 6.1% |
| Selected WACC | 5.2% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for RLF.SW:
cost_of_equity (5.30%) = risk_free_rate (1.25%) + equity_risk_premium (5.60%) * adjusted_beta (0.47) + risk_adjustments (1.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.